Incidence and reproduction numbers of pertussis: Estimates from Serological and Social Contact Data in Five European Countries

PLoS Medicine

Volumn 7, Issue 6, 2010, Pages

  Kretzschmar, Mirjam ^a,b   Teunis, Peter F M ^a,c   Pebody, Richard G ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c EMORY UNIVERSITY   (United States)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PERTUSSIS TOXIN; BACTERIUM ANTIBODY; PERTUSSIS VACCINE;

AGE DISTRIBUTION; ARTICLE; DISEASE ACTIVITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EUROPE; HUMAN; INCIDENCE; PERTUSSIS; SEROLOGY; SEROPREVALENCE; SOCIAL BEHAVIOR; STATISTICAL ANALYSIS; ADOLESCENT; ADULT; AGE; BLOOD; BORDETELLA PERTUSSIS; CROSS-SECTIONAL STUDY; IMMUNOLOGY; LONGITUDINAL STUDY; REPRODUCIBILITY; VACCINATION; VALIDATION STUDY;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CROSS-SECTIONAL STUDIES; EUROPE; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; LONGITUDINAL STUDIES; PERTUSSIS VACCINE; REPRODUCIBILITY OF RESULTS; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 77955029599     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000291     Document Type: Article

References (37)

1. Rohani P, Earn DJ, Grenfell BT (2000) Impact of immunisation on pertussis transmission in England and Wales. Lancet 355: 285-286.
2. Gay NJ, Miller E (2000) Pertussis transmission in England and Wales. Lancet 355: 1553-1554.
3. Schellekens J, von Konig CH, Gardner P (2005) Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J 24: S19-24.
4. Versteegh FG, Mertens PL, de Melker HE, Roord JJ, Schellekens JF, et al. (2005) Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol Infect 133: 737-748.
5. Cortese MM, Baughman AL, Brown K, Srivastava P (2007) A ''new age'' in pertussis prevention new opportunities through adult vaccination. Am J Prev Med 32: 177-185.
6. Hethcote HW (1997) An age-structured model for pertussis transmission. Math Biosci 145: 89-136.
7. Van Rie A, Hethcote HW (2004) Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 22: 3154-3165.
8. van Boven M, de Melker HE, Schellekens JF, Kretzschmar M (2000) Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Math Biosci 164: 161-182.
9. van Boven M, de Melker HE, Schellekens JF, Kretzschmar M (2001) A model based evaluation of the 1996-7 pertussis epidemic in The Netherlands. Epidemiol Infect 127: 73-85.
10. Tozzi AE, Pandolfi E, Celentano LP, Massari M, Salmaso S, et al. (2007) Comparison of pertussis surveillance systems in Europe. Vaccine 25: 291-297.
11. Celentano LP, Massari M, Paramatti D, Salmaso S, Tozzi AE (2005) Resurgence of pertussis in Europe. Pediatr Infect Dis J 24: 761-765.
12. de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M (2006) The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 53: 106-113.
13. Pebody RG, Gay NJ, Giammanco A, Baron S, Schellekens J, et al. (2005) The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect 133: 159-171.
14. Simonsen J, Molbak K, Falkenhorst G, Krogfelt KA, Linneberg A, et al. (2009) Estimation of incidences of infectious diseases based on antibody measurements. Stat Med 28: 1882-1895.
15. Simonsen J, Strid MA, Molbak K, Krogfelt KA, Linneberg A, et al. (2008) Seroepidemiology as a tool to study the incidence of Salmonella infections in humans. Epidemiol Infect 136: 895-902.
16. Deville JG, Cherry JD, Christenson PD, Pineda E, Leach CT, et al. (1995) Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 21: 639-642.
17. Hodder SL, Cherry JD, Mortimer Jr. EA, Ford AB, Gornbein J, et al. (2000) Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis 31: 7-14.
18. Strebel P, Nordin J, Edwards K, Hunt J, Besser J, et al. (2001) Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 183: 1353-1359.
19. Wallinga J, Edmunds WJ, Kretzschmar M (1999) Perspective: human contact patterns and the spread of airborne infectious diseases. Trends Microbiol 7: 372-377.
20. Wallinga J, Teunis P, Kretzschmar M (2006) Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol 164: 936-944.
21. Mossong J, Hens N, Jit M, Beutels P, Auranen K, et al. (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5: e74. doi:10.1371/journal.pmed.0050074.
22. Giammanco A, Chiarini A, Maple PA, Andrews N, Pebody R, et al. (2003) European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 22: 112-120.
23. Versteegh FG, Schellekens JF, Nagelkerke AF, Roord JJ (2002) Laboratoryconfirmed reinfections with Bordetella pertussis. Acta Paediatr 91: 95-97.
24. Teunis PF, van der Heijden OG, de Melker HE, Schellekens JF, Versteegh FG, et al. (2002) Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol Infect 129: 479-489.
25. Diekmann O, Heesterbeek JAP (2000) Mathematical epidemiology of infectious diseases: model building, analysis and interpretation. New York: Wiley.
26. Baughman AL, Bisgard KM, Edwards KM, Guris D, Decker MD, et al. (2004) Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 11: 1045-1053.
27. Smieszek T (2009) A mechanistic model of infection: why duration and intensity of contacts should be included in models of disease spread. Theor Biol Med Model 6: 25.
28. Kretzschmar M, Mikolajczyk RT (2009) Contact profiles in eight European countries and implications for modelling the spread of airborne infectious diseases. PLoS One 4: e5931. doi:10.1371/journal.pone.0005931.
29. Anderson RM, May RM (1991) Infectious disease of humans: dynamics and control. Oxford: Oxford University Press.
30. Wallinga J, Teunis P, Kretzschmar M (2003) Reconstruction of measles dynamics in a vaccinated population. Vaccine 21: 2643-2650.
31. van Boven M, Kretzschmar M, Wallinga J, O'Neill P, Wichmann O, et al. (2010) Estimation of measles vaccine efficacy and critical vaccination coverage in a highly vaccinated population. J Roy Soc Interface, In press.
32. Edmunds WJ, Gay NJ, Kretzschmar M, Pebody RG, Wachmann H (2000) The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect 125: 635-650.
33. Richardson M, Elliman D, Maguire H, Simpson J, Nicoll A (2001) Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J 20: 380-391.
34. Mooi FR, van Loo IH, King AJ (2001) Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis 7: 526-528.
35. De Greeff SC, Dekkers AL, Teunis P, Rahamat-Langendoen JC, Mooi FR, et al. (2009) Seasonal patterns in time series of pertussis. Epidemiol Infect 137: 1388-1395.
36. Storsaeter J, Hallander HO, Gustafsson L, Olin P (2003) Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 21: 3542-3549.
37. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J (2005) Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 24: S25-S34.